Mereo BioPharma Group plc
MREO
$0.24
$0.00-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.27% | -39.52% | -35.81% | 28.41% | 21.56% |
| Total Receivables | -38.98% | -46.01% | 85.50% | 45.51% | 3.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 41.85% | -82.23% | -34.79% | -26.84% | -72.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.34% | 278.72% | -85.27% | -59.96% | -35.50% |
| Total Current Assets | -39.78% | -39.57% | -34.62% | 25.05% | 17.26% |
|
|
|||||
| Total Current Assets | -39.78% | -39.57% | -34.62% | 25.05% | 17.26% |
| Net Property, Plant & Equipment | -61.28% | -54.90% | -44.07% | -40.84% | -40.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.75% | -19.52% | -45.73% | -43.00% | -40.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -39.89% | -39.60% | -34.85% | 22.14% | 14.87% |
|
|
|||||
| Total Accounts Payable | -46.62% | -50.93% | -64.84% | 28.76% | 14.02% |
| Total Accrued Expenses | -48.71% | -22.42% | -11.32% | 9.80% | -20.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -96.76% | -93.69% | -89.29% | -85.88% | 857.36% |
| Total Finance Division Other Current Liabilities | -8.68% | -11.45% | 15.87% | 13.76% | -51.82% |
| Total Other Current Liabilities | -8.68% | -11.45% | 15.87% | 13.76% | -51.82% |
| Total Current Liabilities | -68.93% | -57.66% | -51.14% | -31.87% | 45.98% |
|
|
|||||
| Total Current Liabilities | -68.93% | -57.66% | -51.14% | -31.87% | 45.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -79.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -49.57% | -38.56% | -38.60% | -45.61% | 17.86% |
| Total Liabilities | -67.57% | -56.79% | -51.63% | -37.09% | -3.39% |
|
|
|||||
| Common Stock & APIC | 1.85% | 2.17% | 2.18% | 11.78% | 11.01% |
| Retained Earnings | -8.24% | -8.30% | -10.39% | -10.14% | -10.31% |
| Treasury Stock & Other | 42.58% | 1.75% | 52.71% | 16.37% | -0.72% |
| Total Common Equity | -32.89% | -35.76% | -31.12% | 40.25% | 20.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.89% | -35.76% | -31.12% | 40.25% | 20.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.89% | -35.76% | -31.12% | 40.25% | 20.64% |
|
|
|||||